Gossamer Bio, Inc. (GOSS): Price and Financial Metrics


Gossamer Bio, Inc. (GOSS): $7.60

0.22 (+2.98%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GOSS to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

GOSS Stock Price Chart Interactive Chart >

Price chart for GOSS

GOSS Price/Volume Stats

Current price $7.60 52-week high $14.30
Prev. close $7.38 52-week low $6.28
Day low $7.11 Volume 553,000
Day high $7.64 Avg. volume 772,552
50-day MA $8.28 Dividend yield N/A
200-day MA $10.18 Market Cap 586.09M

Gossamer Bio, Inc. (GOSS) Company Bio


Gossamer Bio, Inc. operates as a biopharmaceutical company, which focuses on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.


GOSS Latest News Stream


Event/Time News Detail
Loading, please wait...

GOSS Latest Social Stream


Loading social stream, please wait...

View Full GOSS Social Stream

Latest GOSS News From Around the Web

Below are the latest news stories about Gossamer Bio Inc that investors may wish to consider to help them evaluate GOSS as an investment opportunity.

Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q2 2021 Results - Earnings Call Transcript

Gossamer Bio, Inc. (GOSS) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Bryan Giraudo - Chief Financial Officer Faheem Hasnain - Chairman, Co-Founder and Chief Executive Officer Richard Aranda - Chief Medical Officer Conference Call Participants Joseph Schwartz - SVB Leerink Olivia Brayer - Bank...

SA Transcripts on Seeking Alpha | NA NA, NA

Read More 'GOSS' Stories Here

GOSS Price Returns

1-mo 9.99%
3-mo -15.84%
6-mo -29.89%
1-year -10.27%
3-year -59.34%
5-year N/A
YTD -32.80%
2021 16.96%
2020 -38.13%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.375 seconds.